Yechezkel Bareholz

Title: Yechezkel Bareholz: Innovator in Hepatitis B Virus Vaccination

Introduction

Yechezkel Bareholz is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of immunology, particularly in the development of vaccines against Hepatitis B virus (HBV). His innovative approach utilizes sphingoid-polyalkylamine conjugates to enhance immune responses.

Latest Patents

Yechezkel Bareholz holds a patent for "Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination." This invention focuses on the use of sphingoid-polyalkylamine conjugates as capturing agents for biologically active molecules, such as antigens. The patent outlines methods for stimulating or enhancing an immune response to protect against HBV infection. A preferred conjugate mentioned in the patent is N-palmitoyl D-erythro sphingosyl-1-carbamoyl spermine (CCS).

Career Highlights

Throughout his career, Yechezkel Bareholz has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem and Bio-Lab, Inc. His work has been instrumental in advancing vaccine technology and improving public health outcomes.

Collaborations

Yechezkel has collaborated with notable individuals in his field, including Eliezer Kedar and Sarit Samira. These partnerships have contributed to the development and refinement of his innovative approaches to vaccination.

Conclusion

Yechezkel Bareholz is a pioneering inventor whose work in Hepatitis B virus vaccination showcases the potential of innovative conjugate technologies. His contributions to immunology continue to influence the development of effective vaccines.